文献速递免疫规划卫生政策与健康促进

疫苗超剂量接种的安全性:VAERS 2007-2017年报告分析

Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
PubMed 文献 · Vaccine · 2019-05-30

本研究检索2007年1月1日至2018年1月26日VAERS数据库中美国疫苗超剂量接种报告,共366815份报告中5067份(1.4%)涉及超剂量接种,其中3898份(76.9%)未描述不良健康事件。在有不良健康事件报告中,最常见为发热、注射部位红斑、注射部位疼痛和头痛,其比例与同期所有VAERS报告相当,未发现意外条件或不良事件聚集。

要点

  • 超剂量接种报告占VAERS总报告1.4%,其中76.9%未报告不良健康事件。
  • 最常见疫苗为三价灭活流感疫苗、水痘疫苗、甲肝疫苗和麻腮风水痘联合疫苗。
  • 有不良健康事件报告中最常见为发热、注射部位红斑、注射部位疼痛和头痛。

核心结论

  • 超过四分之三的疫苗超剂量接种报告未描述不良健康事件。
  • 在有不良健康事件报告中,未观察到意外条件或不良事件聚集。

研究设计与样本

  • 研究检索VAERS数据库2007年1月1日至2018年1月26日美国疫苗超剂量接种报告。
  • 共纳入366815份VAERS报告,其中5067份(1.4%)报告超剂量接种。
  • 对所有严重报告和随机抽样的非严重报告进行病历回顾。
  • 将超剂量接种报告中最常见不良事件与同期所有VAERS报告对应不良事件进行比较。

主要发现

  • 5067份超剂量接种报告中,3898份(76.9%)未描述不良健康事件。
  • 报告最多的疫苗为三价灭活流感疫苗(15.4%)、水痘疫苗(13.9%)、甲肝疫苗(11.4%)和麻腮风水痘联合疫苗(11.1%)。
  • 仅报告不良健康事件的报告中,最常见为发热(12.8%)、注射部位红斑(9.7%)、注射部位疼痛(8.9%)和头痛(6.6%)。
  • 超剂量接种报告的不良健康事件比例与同期所有VAERS报告相当。

临床怎么用

  • 预防医学与公共卫生医生可参考本研究表明疫苗超剂量接种后严重不良事件罕见。
  • 对于超剂量接种者,应关注发热、注射部位反应和头痛等常见不良事件。
  • 超剂量接种后不良事件谱与常规接种相似,无需特殊担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The administration of an extra dose of a vaccine may occur due to a programmatic error (e.g., vaccination error) when there is need to provide one of the antigens of a combination vaccine not readily available as a single antigen, or when there is need to provide immunization in a person with uncertain vaccination histories (e.g., refugees). There is little data available on the safety of an extra dose of vaccine. OBJECTIVE: To assess for the presence of adverse events (AEs) most commonly reported following the administration of excess doses of vaccine in the Vaccine Adverse Event Reporting System (VAERS). METHODS: We searched VAERS for US reports where an excess dose of vaccine was administered to a person received from 1/1/2007 through 1/26/2018. We reviewed medical records for all serious reports and a random sample of non-serious reports. The most common AEs among reports of excess dose of vaccine administered were compared with the corresponding AEs for all vaccines reported to VAERS during the same period. RESULTS: Out of 366,815 total VAERS reports received, 5067 (1.4%) reported an excess dose of vaccine was administered; 3898 (76.9%) did not describe an adverse health event (AHE). The most common vaccines reported were trivalent inactivated influenza (15.4%), varicella (13.9%), hepatitis A (11.4%), and measles, mumps, rubella, varicella (11.1%). Among reports where only AHEs were reported, the most common were pyrexia (12.8%), injection site erythema (9.7%), injection site pain (8.9%), and headache (6.6%). The percentage of AHEs among these reports was comparable to all reports submitted to VAERS during the same study period. CONCLUSION: More than three-fourths of reports of an excess dose of vaccine did not describe an AHE. Among reports where an AHE event was reported, we did not observe any unexpected conditions or clustering of AEs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Moro PL, Arana J, Marquez PL, et al. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017. Vaccine. 2019. PMID: 31155414. doi:10.1016/j.vaccine.2019.04.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。